Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of the Relevance of the HLA-G Immune Checkpoint in Cancer Immunotherapy

NCT04300088 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04300088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04300088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of the Relevance of the HLA-G Immune Checkpoint in Cancer Immunotherapy
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Unknown status
Start date
March 10, 2020
Completion date
September 10, 2025
Enrollment
281 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor